Novel immunosuppressive...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 211/60 (2006.01) A61K 31/40 (2006.01) A61K 31/445 (2006.01) A61K 31/52 (2006.01) C07D 207/16 (2006.01) C07D 401/12 (2006.01) C07D 401/14 (2006.01) C07D 403/12 (2006.01) C07D 405/12 (2006.01) C07D 405/14 (2006.01) C07D 409/12 (2006.01) C07D 471/04 (2006.01) C07D 473/00 (2006.01)

Patent

CA 2102180

The present invention relates to novel class of immunosuppressive compounds having an affinity for the FK-506 binding protein (FKBP). Once bound to this protein, the immunosuppressive compounds inhibit the prolyl peptidyl cis- trans isomerase (rotamase) activity of the FKBP and inhibit T cell activation. As such, the compounds of this invention can be used as immunosuppressive drugs to prevent or significantly reduce graft rejection in bone marrow and organ transplantations and for use in the treatment of a wide variety of autoimmune diseases in humans and other mammals. These compounds are represented by formula (I), in which the different substituents are defined in the description. Image

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel immunosuppressive... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel immunosuppressive..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel immunosuppressive... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1769465

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.